Expressing medicine side effects: Assessing the effectiveness of absolute risk, relative risk, and number needed to harm, and the provision of baseline risk information-Reference-Cited by-同舟云学术

Expressing medicine side effects: Assessing the effectiveness of absolute risk, relative risk, and number needed to harm, and the provision of baseline risk information

Published:2006-10 Issue:1-2 Volume:63 Page:89-96
ISSN:0738-3991
Container-title:Patient Education and Counseling
language:en
Short-container-title:Patient Education and Counseling

Author:

Berry Dianne C.,Knapp Peter,Raynor Theo

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Informing patients: an assessment of the quality of patient information leaflets;Coulter,1998

2. Comparative evaluation of patient information leaflets by pharmacists, doctors and the general public;Mottram;J Clin Pharm Ther,1997

3. Shared decision-making in the medical context: what does it mean? (or it takes at least two to tango);Charles;Soc Sci Med,1997

4. Risk, communication and health psychology;Berry,2004

5. Number needed to treat or harm (NNT/NNH);Anon.;Bandolier,1997

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laypersons’ understanding of statistical concepts commonly used in prescription drug promotion: A review of the research literature;Research in Social and Administrative Pharmacy;2024-09

2. Influence of side effect information on patient willingness to take medication: consequences for informed consent and medication adherence;Internal Medicine Journal;2023-09

3. A systematic review of relative risks for the relationship between chronic alcohol use and the occurrence of disease;Alcohol: Clinical and Experimental Research;2023-07

4. How people use information about changes in infections and disease prevalence.;Health Psychology;2023-06

5. Historical Review of the Use of Relative Risk Statistics in the Portrayal of the Purported Hazards of High LDL Cholesterol and the Benefits of Lipid-Lowering Therapy;Cureus;2023-05-01